Tyra Biosciences, Inc. (TYRA)
$19.94-0.15%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.2B
- Beta
- 0.73
- P/E (TTM)
- -8.43
- Short % float
- 21.24%
- Days to cover
- 8.8
- SI change
- -4.7%
- 1W
- -2.40%
- 1M
- -15.29%
- vs SPY 1W
- -3.56%
- vs SPY 1M
- -18.29%
Industry peers
FMP comparable companies · ranked by market cap
- DAWNDay One Biopharmaceuticals, Inc.$2.2B$21.53
- MRVIBUYMaravai LifeSciences Holdings, Inc.$2.2BCRISISQ -1$7.90+3.19%
- NBTXSELLNanobiotix S.A.$1.3BCRISISQ 18$25.75+3.41%
- SVRASELLSavara Inc.$986MRECOVERYQ 11$4.81+1.86%
- KURASELLKura Oncology, Inc.$945MBEARQ 12$10.65+0.76%
- GERNSELLGeron Corporation$770MRECOVERYQ 11$1.20+0.82%
- PROKSELLProKidney Corp.$578MRECOVERYQ 1$1.72+4.82%
- PRMEBUYPrime Medicine, Inc.$538MRECOVERYQ -6$2.98+11.45%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 20
- VALUE
- 8
- GROWTH
- 47
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-27.8%
REV YoY-
ROE-46.4%
EPS YoY-
ROA-38.8%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-8.43
P/E FWD-
SECTOR PE20.47
INDUSTRY PE13.95
P/B3.78
P/FCF-
EV/EBITDA-7.70
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E1.58
ALTMAN Z-
CURR RATIO14.91
ND/EBITDA-
BETA0.73
